← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Epicypher, Inc.
Research Triangle Park, NC
$79,121,697
Total funding
59
Grants
Funding over time
peak $12.6M · FY2014–25$20M$15M$10M$5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$79,121,697 · 59
By mechanism
R44$71,718,754 · 33
R43$6,578,193 · 23
R41$824,750 · 3
Investigators at Epicypher, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
Novel recombinant sensors to study histone ubiquitin signaling$1,276,822
R44 · FY2023 · GM
Versatile genomics platform for unbiased analysis of chromatin-associated RNAs and nascent transcripts$1,274,993
R44 · FY2024 · AG
Versatile platform for genome-wide R-loop mapping for aging and neurodegenerative disease research$1,274,958
R44 · FY2025 · AG
Versatile platform for genome-wide R-loop mapping for aging and neurodegenerative disease research$1,274,632
R44 · FY2024 · AG
Biochemical and genomic tools to study histone ADP ribosylation signaling$1,274,494
R44 · FY2024 · GM
Biochemical and genomic tools to study histone ADP ribosylation signaling$1,274,280
R44 · FY2025 · GM
Novel recombinant sensors to study histone ubiquitin signaling$1,273,178
R44 · FY2024 · GM
Multiomic genomic mapping with long read sequencing$1,272,936
R44 · FY2023 · GM
Multiomic genomic mapping with long read sequencing$1,270,748
R44 · FY2024 · GM
Versatile genomics platform for unbiased analysis of chromatin-associated RNAs and nascent transcripts$1,267,289
R44 · FY2025 · AG
Asymmetric nucleosome substrates to advance the study of the histone code$1,264,176
R44 · FY2025 · GM
Development of novel epigenetic biomarkers and detection reagents for aging$1,249,147
R44 · FY2025 · AG
Accelerated discovery of methylation targeted therapeutic development$1,148,788
R44 · FY2018 · CA
Epigenomic analysis of cell-free nucleosomes for cancer research$1,047,610
R44 · FY2025 · CA
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping$1,035,703
R44 · FY2023 · HG
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping$1,032,776
R44 · FY2024 · HG
A molecular toolbox to accelerate drug development for histone lysine methylation regulators$1,025,085
R44 · FY2022 · TR
A molecular toolbox to accelerate drug development for histone lysine methylation regulators$1,025,085
R44 · FY2023 · TR
Single-Cell Chromatin Mapping Assays$1,024,878
R44 · FY2021 · GM
Development of efficient quantitative chromatin profiling in kit and high-throughput formats$1,024,792
R44 · FY2021 · HG